Filing Details
- Accession Number:
- 0001643498-17-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-17 18:42:35
- Reporting Period:
- 2017-05-15
- Filing Date:
- 2017-05-17
- Accepted Time:
- 2017-05-17 18:42:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1628908 | Evolent Health Inc. | EVH | Services-Management Services (8741) | 320454912 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643498 | Iii Thomas Peterson | C/O Evolent Health, Inc. 800 N. Glebe Road, Suite 500 Arlington VA 22203 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2017-05-15 | 20,777 | $25.00 | 341,092 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2017-05-15 | 20,777 | $24.99 | 320,315 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2017-05-15 | 20,777 | $24.99 | 299,538 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2017-05-15 | 20,777 | $24.99 | 278,761 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017.
- The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.90-$25.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.90-$25.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.85-$25.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.85-$25.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
